SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001297184-22-000007
Filing Date
2022-03-11
Accepted
2022-03-11 16:13:54
Documents
117
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K amph-20211231x10k.htm   iXBRL 10-K 4449851
2 EX-21.1 amph-20211231xex21d1.htm EX-21.1 15027
3 EX-23.1 amph-20211231xex23d1.htm EX-23.1 11912
4 EX-31.1 amph-20211231xex31d1.htm EX-31.1 19822
5 EX-31.2 amph-20211231xex31d2.htm EX-31.2 19355
6 EX-32.1 amph-20211231xex32d1.htm EX-32.1 9679
7 EX-32.2 amph-20211231xex32d2.htm EX-32.2 9853
8 GRAPHIC amph-20211231x10k001.jpg GRAPHIC 54698
  Complete submission text file 0001297184-22-000007.txt   17177504

Data Files

Seq Description Document Type Size
9 EX-101.SCH amph-20211231.xsd EX-101.SCH 90134
10 EX-101.CAL amph-20211231_cal.xml EX-101.CAL 110987
11 EX-101.DEF amph-20211231_def.xml EX-101.DEF 402582
12 EX-101.LAB amph-20211231_lab.xml EX-101.LAB 725374
13 EX-101.PRE amph-20211231_pre.xml EX-101.PRE 695890
111 EXTRACTED XBRL INSTANCE DOCUMENT amph-20211231x10k_htm.xml XML 3481172
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36509 | Film No.: 22733283
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences